Zeford 1 Tablet contains Clonazepam 1mg, a benzodiazepine derivative with potent anticonvulsant, anxiolytic, muscle relaxant, and sedative properties. It is primarily indicated for the management of seizure disorders, including absence seizures, myoclonic seizures, and Lennox-Gastaut syndrome. Additionally, Zeford 1 is utilized in the treatment of panic disorders and anxiety-related conditions. Clonazepam acts by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, thereby stabilizing neuronal membranes and reducing excessive excitability. The onset of action is rapid, making it effective for acute symptom control. Dosage should be individualized based on the patient’s clinical response and tolerability, with careful titration to minimize adverse effects such as drowsiness, dizziness, and impaired coordination. Long-term use requires monitoring due to the potential for tolerance, dependence, and withdrawal symptoms upon abrupt discontinuation. Caution is advised in patients with hepatic impairment, respiratory disorders, or a history of substance abuse. Zeford 1 Tablet should be used under strict medical supervision, and patients should avoid concomitant use of alcohol or other central nervous system depressants to prevent additive sedation and respiratory depression.